Corvia Medical, Inc. is revolutionizing the treatment of heart failure (HF) with a novel transcatheter structural heart device.
Tewksbury, MA
Joined June 2018
- Tweets162
- Following32
- Followers81
- Likes39
Corvia is proud to support the @MedUnivSC #charlestonHFpEF Conference from July 19-21. Heart failure with preserved ejection fraction (#HFpEF) is a hot topic — join course director @LitwinSheldon & other esteemed faculty to discover why! #heartfailure #atrialshunt #cardiotwitter
#CSIFrankfurt2024 is here! Don't miss today's session on #Interatrialshunt therapy at 16:15 CEST. With two #atrialshunt randomized trials now complete, come hear @amin_polzin discuss why the #Corvia Atrial Shunt holds promise for #HFpEF patients!
#cardiotwitter #structuralheart
#CSIFrankfurt2024 is almost here! Don't miss Wednesday's #Interatrialshunt Workshop where @amin_polzin from @UniklinikDUS will share lessons learned from REDUCE LAP-HF II & how these findings are being validated in #RESPONDERHF. #atrialshunt #HFpEF #cardiotwitter #heartfailure
Jimmy's story gives us confidence we are on the right path with our confirmatory trial #RESPONDERHF. Learn more at treatmyheartfailure.com.
@LitwinSheldon #HFpEF #atrialshunt
Caution: Investigational device, limited by US law to investigational use.
postandcourier.com/health/mu…
Great interview with @HFpEF regarding the favorable long-term effects of an #atrialshunt observed in REDUCE LAP-HF II #heartfailure patients.
Interview with Sanjiv J. Shah, MD, author of "Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial" hosted by James E. Udelson, MD. @HFpEF ja.ma/3JoyPLC
What is the long-term effect of an #atrialshunt? Recently published data in @JAMACardio by @RBPatelMD shows favorable effects of the Corvia Atrial Shunt on cardiac structure & function in #heartfailure patients. #HFpEF #cardiotwitter
jamanetwork.com/journals/jam…
During #NationalNursesWeek, we extend our deepest appreciation to all the incredible #HeartFailure nurses. Your expertise, empathy, and dedication are instrumental in improving life for millions. Thank you for being the heartbeat of compassionate care. #NursesWeek2024 #Corvia
Happy #NationalNursesDay to all the dedicated heart failure nurses! Your unwavering commitment & compassion make a significant impact on the lives of #heartfailure patients. Your dedication makes all the difference.
#NursesMakeTheDifference #GratefulHeart #NursesWeek2024 #Corvia
Corvia Medical, Inc. retweeted
Corvia Highlights Importance of Patient Selection in RESPONDER-HF Atrial Shunt Trial | @corviamedical citoday.com/news/corvia-high…
We continue to learn which #heartfailure patients may benefit most from #atrialshunt therapy. Recent RELIEVE-HF data reinforces the importance of patient selection and suggests we are on the right path with #RESPONDERHF to confirm optimal #HFpEF patients.
us.corviamedical.com/corvias…
It's the last day of #ACC24, but there's still time time to come learn about #atrialshunt therapy and which #HFpEF patients might from participating in the #RESPONDERHF trial. Come see us at booth 3338!
#CardioTwitter #HeartFailure
Congratulations to @vijayswarup and the @ArizonaRhythm team for the great coverage of their REDUCE LAP-HF II patient and their ongoing work to bring #atrialshunt therapy to #heartfailure patients in AZ. fox10phoenix.com/video/14166…
#HFpEF #CardioTwitter #clinicaltrials #RESPONDERHF
FACT: #HeartFailure affects 6.2 million people in the US—this may include someone you love.
Join #Corvia this #HeartMonth to prioritize #hearthealth awareness. Your knowledge could change a life. Learn more about heart failure here: bit.ly/3SsnXjO
#twittercardio
February is American #HeartMonth ❤️, a time to raise awareness about heart health and cardiovascular disease. #CorviaMedical is proud to be part of the solution to improve the lives of millions of people who suffer from heart disease.
#HeartMonth2024 #cardiotwitter #corvia
As the year comes to a close, we want to take a moment to express our #gratitude to our investigators, customers, and partners for their support throughout the year. May this #holidayseason bring you love, light, and laughter, and the New Year bring much #prosperity & #success.
We hope to see you in Wiesbaden, Germany at #CSIFocusDHF! Thanks in advance to Prof. Rudin Pistulli who will present his experience with the #Corvia Atrial Shunt and to @CSIcongress for its continued focus on the potential of #atrialshunt therapy for #heartfailure. #CSIDHF
#Heartlive in Munich begins later this week! Hear from the experts - Profs. Ulf Landmesser, Martin Bergmann, and Mirjam Keßler - at our symposium on #atrialshunt therapy for #HFpEF. Stop by booth #13 and learn about our confirmatory trial #RESPONDERHF. #Corvia #heartfailure
Congratulations to @vikjag45 and the team at @WVUMedicine for leading the way and being the first center in West Virginia to enroll a patient in the #RESPONDERHF trial. Together, we are working to give #heartfailure patients another reason to hope. #HFpEF #atrialshunt
This Post is from an account that no longer exists. Learn more
In “BNP: Biomarker Not Perfect in heart failure with preserved ejection fraction”, @HFpEF shares imperfections in using NPs in #HFpEF.
Corvia's #RESPONDERHF #atrialshunt trial includes these HFpEF pts with low NPs who might otherwise be overlooked.
doi.org/10.1093/eurheartj/eh…
#Heartfailure expert and PI for Corvia's RESPONDER-HF trial, @LitwinSheldon from @MedUnivSC describes the unmet need of #HFpEF and how #atrialshunt therapy, being evaluated through #RESPONDERHF, could be a game-changer for patients & clinicians. #clinicaltrials #CardioTwitter
A Lifesaving Shunt in the Heart? | By Dr. Sheldon Litwin "Approximately 60 study sites worldwide are participating in RESPONDER-HF, a randomized clinical trial of the Corvia Atrial Shunt." Read what this expert has to say. infomeddnews.com/a-lifesavin…